Press release
Investigation announced for Investors in Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) over potential Wrongdoing by certain directors
An investigation on behalf of investors in Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) shares.
Investors who purchased shares of Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Reviva Pharmaceuticals Holdings officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.
Cupertino, CA based Reviva Pharmaceuticals Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases.
On April 15, 2024, Reviva Pharmaceuticals Holdings, Inc. filed with the SEC a current report on Form 8-K. In this current report, Reviva Pharmaceuticals announced that "the Company's previously issued financial statements for the fiscal year ended December 31, 2022 included in its Annual Report on Form 10-K, the interim financial statements for the quarterly period ended September 30, 2022 included in its Quarterly Report on Form 10-Q, and each of the interim financial statements for the quarterly periods in fiscal 2023 included in its Quarterly Reports on Form 10-Q (cumulatively, the "Restatement Periods") should be restated to correct historical errors related principally to the timing of recognition of the Company's estimated accrual of certain research and development expenses, and should therefore no longer be relied upon."
Shares of Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) declined from over $8 per share in May 2023 to as low as $1.60 per share on May 15, 2024.
Those who purchased shares of Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Investors in Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) over potential Wrongdoing by certain directors here
News-ID: 3560791 • Views: …
More Releases from Shareholders Foundation, Inc.
Lawsuit Alert: Investors who lost money with shares of Molina Healthcare, Inc. ( …
An investor, who purchased shares of Molina Healthcare, Inc. (NYSE: MOH), filed a lawsuit over alleged violations of Federal Securities Laws by Molina Healthcare, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Molina Healthcare, Inc. (NYSE: MOH) have certain options and for certain investors are short and strict deadlines running. Deadline: December 02, 2025. NYSE: MOH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
CTO Realty Growth, Inc. (NYSE: CTO) Long Term Investor Alert: Investigation of p …
An investigation on behalf of current long-term investors in shares of CTO Realty Growth, Inc. (NYSE: CTO) concerning potential breaches of fiduciary duties by certain directors and officers of CTO Realty Growth, Inc. was announced.
Investors who are current long term investors in CTO Realty Growth, Inc. (NYSE: CTO) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a…
Lawsuit filed for Investors who lost money with shares of Marex Group plc (NASDA …
An investor, who purchased shares of Marex Group plc (NASDAQ: MRX), filed a lawsuit in the U.S. District Court for the Southern District of New York over alleged violations of Federal Securities Laws by Marex Group plc in connection with certain allegedly false and misleading statements.
Investors who purchased a significant amount of shares of Marex Group plc (NASDAQ: MRX) between May 16, 2024 and August 5, 2025, have certain options…
LifeMD, Inc. (NASDAQ: LFMD) Investor Alert: Deadline in Lawsuit on October 27, 2 …
A deadline is coming up on October 27, 2025 in the lawsuit filed for certain investors of LifeMD, Inc. (NASDAQ: LFMD) over alleged securities laws violations by LifeMD, Inc.
Investors who purchased shares of LifeMD, Inc. (NASDAQ: LFMD) have certain options and there are strict and short deadlines running. Deadline: October 27, 2025. LifeMD, Inc. (NASDAQ: LFMD) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -…
More Releases for Reviva
Schizophrenia Market Set to Grow Substantially Through 2034, DelveInsight Projec …
The Key Schizophrenia Companies in the market include - Reviva Pharmaceuticals, Minerva Neurosciences, Karuna Therapeutics, Acadia Pharmaceuticals, Boehringer Ingelheim, Sunovion Pharmaceuticals (Sumitomo Pharma)/Otsuka Pharmaceutical, Lyndra Therapeutics, Laboratorios Farmaceuticos Rovi, Newron Pharmaceuticals, Cerevel Therapeutics, AstraZeneca, Eli Lilly and Company, Karuna Therapeutics, Neurocrine Biosciences, and others.
DelveInsight's "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Schizophrenia, historical and forecasted epidemiology as well as the Schizophrenia market trends…
Schizophrenia Market Is Expected to Showcase a Significant Growth During the For …
Recent research indicates that long-acting injectables (LAIs) may be more effective than oral medications in reducing the risk of hospitalization for schizophrenia. Injectables like ARISTADA|ARISTADA INITIO (aripiprazole lauroxil), ABILIFY MAINTENA (aripiprazole), INVEGA PRODUCTS, RISPERDAL CONSTA (risperidone), PERSERIS (risperidone), and other injectables play a significant role in this domain.
According to DelveInsight, the Schizophrenia Market is projected to expand in the forthcoming years due to the growing prevalence of schizophrenia patients in…
Skin Care Peels Market Growing Popularity and Emerging Trends | Reviva Labs, Ski …
The latest study released on the Global Skin Care Peels Market by AMA Research evaluates market size, trend, and forecast to 2030. The Skin Care Peels market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analyzed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the competitors.…
Depression-MDD Drugs Market: Reviva Pharmaceuticals Holdings, H. Lundbeck, Glaxo …
The Depression-MDD Drugs Market research report offers in-depth information to acknowledge the imperative parts of the market that align demand, raw materials, and capacity; this helps make strategic decisions. In addition, the analysis provides demands for the future, besides the available opportunities for an individual. The study focuses on industry chain analysis, upstream and downstream raw material suppliers, key players, production process analysis, cost analysis, market distribution channels, and major…
Global Skin Care Peels Market Analysis 2020 Reviva Labs, Bliss, SkinCeuticals, N …
Global Skin Care Peels market represents the advanced technology manufacturer with high quality data such as segment wise data, region wise data and qualitative analysis of the data which is collected from industry expert and market participants across the key points of market value chain. The market report is also comes up with the comprehensive study of Skin Care Peels market insight, historical data from 2015-2019, forecast data from 2020-2025,…
Business Opportunities in Skin Care Masks Market - Key Drivers, Olay, Estee Laud …
This Global Skin Care Masks report 2024 focus on global and regional market, providing information on major players like manufacturers, suppliers, distributors, traders, customers, investors and etc., major types, major applications from global and major regions such as Europe, North America, China, Japan, Southeast Asia and etc. Data type include capacity, production, market share, price, revenue, cost, gross, gross margin, growth rate, consumption, import, export and etc. Industry chain, manufacturing…
